WS Audiology

Cirrus Logic Senior Technical Fellow John Melanson Awarded 500th US Patent

Retrieved on: 
星期五, 七月 22, 2022
Semiconductor, Manufacturing, Consumer Electronics, Technology, Audio, Video, General Entertainment, Other Entertainment, Music, Film & Motion Pictures, Other Technology, Telecommunications, Entertainment, VoIP, Mobile, Wireless, Engineering, Kool-Aid, Name, Light-emitting diode, Melanson, View, Environment, WS Audiology, Electronic circuit, Human, Citadel (U.S. Senate), Mentorship, Academy of Motion Picture Arts and Sciences, Electronics, LED, Cirrus Logic, Patent, Multimedia, 94th Academy Awards, Semiconductor, Academy, Lighting, Achievement, Technology, Creativity, Heart, Logic, Senate, 500th Military Intelligence Brigade (United States), DSPS, Television, Cirrus

John Melanson, senior technical fellow at Cirrus Logic (Nasdaq: CRUS), has been granted his 500th U.S. patent, an achievement that places him among the worlds most prolific inventors.

Key Points: 
  • John Melanson, senior technical fellow at Cirrus Logic (Nasdaq: CRUS), has been granted his 500th U.S. patent, an achievement that places him among the worlds most prolific inventors.
  • View the full release here: https://www.businesswire.com/news/home/20220718005613/en/
    John Melanson, senior technical fellow at Cirrus Logic, has been granted his 500th U.S. patent, an achievement that places him among the worlds most prolific inventors.
  • Working at Cirrus Logic has given me the ideal backdrop for creativity and invention, said Melanson.
  • Cirrus Logic and Cirrus are trademarks of Cirrus Logic Inc. All other product names noted herein may be trademarks of their respective holders.

Neuromod Establishes Global Commercial Leadership Team

Retrieved on: 
星期三, 四月 6, 2022
Hearing, Tongue, Sonova, Leadership, WS, Marketing, Audiology, EQT, Fund of funds, CEO, Bristol Myers Squibb, Cardinal Health, Corporate development, Akwa Ibom State Association of Nigeria, USA Inc., Private equity, Global Commercial Credit, Acquisition, Patient, Tinnitus, Management, Pharmaceutical industry, WS Audiology

DUBLIN, April 6, 2022 /PRNewswire/ --Neuromod Devices Ltd. has announced the formation of a global commercial leadership team to direct the commercialisation of its Lenire tinnitus treatment device through key partnerships.

Key Points: 
  • DUBLIN, April 6, 2022 /PRNewswire/ --Neuromod Devices Ltd. has announced the formation of a global commercial leadership team to direct the commercialisation of its Lenire tinnitus treatment device through key partnerships.
  • The establishment of the team sees the organisation's U.S. leadership executives Tish Ramirez, Holly Dean, and Stephanie Glowacki join its existing commercial leadership to establish a cross-functional group with significant sales, marketing, finance, and clinical experience in the hearing healthcare industry.
  • In addition to his role as CEO of Neuromod USA Inc., Neuromod's wholly owned U.S. subsidiary, Eric Timm has been appointed President, Global Commercial Operations to head the newly formed team with global responsibility for the organisation's commercial strategy.
  • "Since joining Neuromod I have seen first-hand the tremendous outcomes tinnitus patients have achieved using Lenire and I'm looking forward to working with our commercial team to make that a reality for more people living with the condition", says Eric Timm, President, Global Commercial OperationsandCEO, Neuromod USA.

Hearing Aids Market worth $10.2 billion by 2026 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
星期二, 四月 5, 2022
Adoption, Hearing, Population, Kool-Aid, Growth, Adult, Hearing loss, Patient, Gesellschaft mit beschränkter Haftung, Huber loss, Sensorineural hearing loss, Incidence, Pediatrics, Prevalence, WS Audiology, LLC, Demant, GN Store Nord, Noise-induced hearing loss, Medical device, Dentistry, Technology

The growing prevalence of hearing loss, the increasing adoption of smart hearing aids due to the rising incidence of noise-induced hearing loss, and technological advancements in hearing aids are among the major factors propelling the growth of this market.

Key Points: 
  • The growing prevalence of hearing loss, the increasing adoption of smart hearing aids due to the rising incidence of noise-induced hearing loss, and technological advancements in hearing aids are among the major factors propelling the growth of this market.
  • The hearing aid devices segment accounted for the largest share of the market, by product segment, in 2020
    Based on product, the hearing aids market is segmented into hearing aid devices and hearing implants.
  • The hearing aids market is segmented into sensorineural hearing loss and conductive hearing loss.
  • The adult patients segment accounted for the largest share of the hearing aids market, by patient type segment, in 2020
    Based on patient type, the hearing aids devices market is segmented into adults and pediatrics.

DGAP-News: MIG Capital leads €22.5 million Series B financing for Mimi Hearing Technologies

Retrieved on: 
星期一, 十二月 20, 2021
Database, Series, CES, Television, Samsung, Electronics, Hearing, Growth, Venture round, WS Audiology, MIG, Heel, CEO, Marketing, Machine learning, Artificial intelligence, Beyerdynamic, VC, Volkswagen, Philips, Precision medicine, Löwe, Technology, Security (finance), Video game, Mobile phone, Infineon Technologies, Astellas Pharma, Apple, BRAIN, Skullcandy, BioNTech

MIG Capital AG, one of Germany's leading venture capital firms, today announces the closing of a 22.5 million Series B funding for Mimi Hearing Technologies, the global leader in hearing wellbeing and audio personalization software.

Key Points: 
  • MIG Capital AG, one of Germany's leading venture capital firms, today announces the closing of a 22.5 million Series B funding for Mimi Hearing Technologies, the global leader in hearing wellbeing and audio personalization software.
  • Mimi licenses their science-based hearing enhancement technology to B2B customers including electronic device manufacturers and streaming providers.
  • "The leading investors of our Series B garnered international attention last year as the founding investors in BioNTech," noted Mimi CFO Moritz Bratzke.
  • Founded in 2014 in Berlin by Philipp Skribanowitz (CEO) and Dr. Nicholas Clark (Chief Scientist), Mimi Hearing Technologies is a world-leading software provider of digital hearing.

Berlin-based Mimi Hearing Technologies Closes $25 million Series B Funding to Become the World's Largest Platform for Hearing Wellbeing

Retrieved on: 
星期三, 十二月 15, 2021
Database, CES, Television, Hearing, Electronics, Growth, Venture round, WS Audiology, NASDAQ, MIG, Heel, CEO, Marketing, Pfizer, Machine learning, Artificial intelligence, Beyerdynamic, COVID-19, VC, Volkswagen, Multimedia, Philips, Skullcandy, Precision medicine, Löwe, Technology, View, Pharmaceutical industry, Mobile phone, Video game, Music, Infineon Technologies, Series, Astellas Pharma, BRAIN, BioNTech

BERLIN, Dec. 15, 2021 /PRNewswire/ -- Mimi Hearing Technologies, the global leader in hearing wellbeing and audio personalizationsoftware, today announced the closing of $25 million in Series B funding.

Key Points: 
  • BERLIN, Dec. 15, 2021 /PRNewswire/ -- Mimi Hearing Technologies, the global leader in hearing wellbeing and audio personalizationsoftware, today announced the closing of $25 million in Series B funding.
  • Mimi licenses their science-based hearing enhancement technology to B2B customers including electronic device manufacturers, streaming providers and hearing aid companies.
  • The additional funding significantly enhances their successful and ongoing efforts to deliver better and healthier hearing experiences to millions of people worldwide.
  • The Series B funding also comes on the heels of newly announced partnerships with San Diego based Cleer Audio and Chinese smartphone OEM Shenzhen Rillya.

Berlin-based Mimi Hearing Technologies Closes $25 million Series B Funding to Become the World's Largest Platform for Hearing Wellbeing

Retrieved on: 
星期三, 十二月 15, 2021
Database, CES, Television, Hearing, Electronics, Growth, Venture round, WS Audiology, NASDAQ, MIG, Heel, CEO, Marketing, Pfizer, Machine learning, Artificial intelligence, Beyerdynamic, COVID-19, VC, Volkswagen, Philips, Skullcandy, Precision medicine, Löwe, Technology, Pharmaceutical industry, Mobile phone, Video game, Infineon Technologies, Series, Astellas Pharma, BRAIN, BioNTech

BERLIN, Dec. 15, 2021 /PRNewswire/ -- Mimi Hearing Technologies, the global leader in hearing wellbeing and audio personalizationsoftware, today announced the closing of $25 million in Series B funding.

Key Points: 
  • BERLIN, Dec. 15, 2021 /PRNewswire/ -- Mimi Hearing Technologies, the global leader in hearing wellbeing and audio personalizationsoftware, today announced the closing of $25 million in Series B funding.
  • Mimi licenses their science-based hearing enhancement technology to B2B customers including electronic device manufacturers, streaming providers and hearing aid companies.
  • The additional funding significantly enhances their successful and ongoing efforts to deliver better and healthier hearing experiences to millions of people worldwide.
  • Founded in 2014 in Berlin by Philipp Skribanowitz (CEO) and Dr. Nicholas Clark (Chief Scientist), Mimi Hearing Technologies is a world-leading software provider of digital hearing.

Neuromod appoints Eric Timm as US Chief Executive Officer

Retrieved on: 
星期一, 九月 13, 2021
Food, Science, Food and Drug Administration, WS, Gustavus Adolphus College, Bristol Myers Squibb, Audiology, FDA, Otorhinolaryngology, Faculty, Health, Cardinal Health, Nose, CEO, University, Northwestern University, Veterans' affairs, Caregiver, Sonova, Marketing, Patient, Ear, United States Department of Veterans Affairs, WS Audiology, Tinnitus, Clinical trial, INSEAD, Science Translational Medicine, United Kingdom, University of Wisconsin–Madison, Doctor of Audiology, Leadership, Brain, MBA, Intelligence, Population, Veteran, Hearing, Tongue, Medical device, Pharmaceutical industry, Management, Dentistry

DUBLIN, Ireland, Sept. 13, 2021 /PRNewswire/ -- Neuromod Devices Ltd, the medical device company which specialises in neuromodulation technologies, has announced the appointment of Mr. Eric Timm as Chief Executive Officer of its recently established US entity, Neuromod USA Inc., effective from 1stOctober 2021.

Key Points: 
  • DUBLIN, Ireland, Sept. 13, 2021 /PRNewswire/ -- Neuromod Devices Ltd, the medical device company which specialises in neuromodulation technologies, has announced the appointment of Mr. Eric Timm as Chief Executive Officer of its recently established US entity, Neuromod USA Inc., effective from 1stOctober 2021.
  • He joins Neuromod from WS Audiology, one of the biggest hearing aid manufacturers in the world, where he was President and Chief Executive Officer of the company's U.S. wholesale business.
  • In August, Neuromod announced the hiring of three experienced hearing healthcare executives to form Neuromod USA's leadership team and prepare for entry to the US market.
  • Stephanie Glowacki joined the organization as Chief Financial Officer, Dr. Tish Ramirez (AuD) as Chief Commercial Officer, and Holly Dean as Director, Commercial Sales.

Neuromod appoints Eric Timm as US Chief Executive Officer

Retrieved on: 
星期一, 九月 13, 2021

DUBLIN, Ireland, Sept. 13, 2021 /PRNewswire/ -- Neuromod Devices Ltd, the medical device company which specialises in neuromodulation technologies, has announced the appointment of Mr. Eric Timm as Chief Executive Officer of its recently established US entity, Neuromod USA Inc., effective from 1stOctober 2021.

Key Points: 
  • - Timm to lead recently established U.S. team
    DUBLIN, Ireland, Sept. 13, 2021 /PRNewswire/ -- Neuromod Devices Ltd, the medical device company which specialises in neuromodulation technologies, has announced the appointment of Mr. Eric Timm as Chief Executive Officer of its recently established US entity, Neuromod USA Inc., effective from 1stOctober 2021.
  • He joins Neuromod from WS Audiology, one of the biggest hearing aid manufacturers in the world, where he was President and Chief Executive Officer of the company's U.S. wholesale business.
  • In August, Neuromod announced the hiring of three experienced hearing healthcare executives to form Neuromod USA's leadership team and prepare for entry to the US market.
  • Stephanie Glowacki joined the organization as Chief Financial Officer, Dr. Tish Ramirez (AuD) as Chief Commercial Officer, and Holly Dean as Director, Commercial Sales.

MedPlus Health Solutions LLC, Harmony Hearing Services LLC, and Audiology Distribution LLC dba HearUSA settled a case against former executives, certain companies, and individuals accused of allegedly breaching contracts, misappropriating trade secrets an

Retrieved on: 
星期四, 五月 20, 2021
Medical specialties, Nervous system, MedPlus, Otology, Sensory systems, WS Audiology, Audiology, Hearing loss, Limited liability company

b'PALM BEACH GARDENS, Fla., May 19, 2021 /PRNewswire/ --On March 3, 2020, Audiology Distribution LLC DBA HearUSA, MedPlus Health Solutions LLC, and Harmony Hearing Services LLC (the "MedPlus Companies") filed a lawsuit in the federal court in Tampa, Florida against Defendants Pete Stephens, Jason Dawson, CentralComp Services LLC, and Unified Hearing Solutions LLC (Case No.

Key Points: 
  • b'PALM BEACH GARDENS, Fla., May 19, 2021 /PRNewswire/ --On March 3, 2020, Audiology Distribution LLC DBA HearUSA, MedPlus Health Solutions LLC, and Harmony Hearing Services LLC (the "MedPlus Companies") filed a lawsuit in the federal court in Tampa, Florida against Defendants Pete Stephens, Jason Dawson, CentralComp Services LLC, and Unified Hearing Solutions LLC (Case No.
  • In the lawsuit, the MedPlus Companies alleged that Stephens, former President of MedPlus, breached his fiduciary duties and engaged in various wrongful activities.
  • Audiology Distribution is a parent company of MedPlus Health Solutions LLC and Harmony Hearing Services LLC.\nMedPlus Health Solutions LLC is a customer service centric, technology driven workers\' compensation claims processing organization that provides time- and money- saving services to claim adjusters, self-insured companies, and other organizations.
  • Harmony Hearing Services LLC provides hearing loss claimants with products that help with hearing challenges.\n'

Hearing Aid Innovator Signia Appoints Mike O'Neil as President

Retrieved on: 
星期四, 一月 7, 2021
Otology, Medical specialties, Nervous system, Otorhinolaryngology, Signia, WS Audiology, Occupational safety and health, Audiology, Hearing aid, Hearing loss

PISCATAWAY, N.J., Jan. 7, 2021 /PRNewswire/ -- Underscoring its commitment to enhancing human performance through pioneering hearing solutions, hearing aid innovator Signia today announced the appointment of Mike O'Neil to serve as President, reporting directly to Daniel Liberman, President, U.S. of parent company WS Audiology.

Key Points: 
  • PISCATAWAY, N.J., Jan. 7, 2021 /PRNewswire/ -- Underscoring its commitment to enhancing human performance through pioneering hearing solutions, hearing aid innovator Signia today announced the appointment of Mike O'Neil to serve as President, reporting directly to Daniel Liberman, President, U.S. of parent company WS Audiology.
  • "The hearing care industry is undergoing exciting change, as shifts in health tech and consumer product trends drive broader acceptance of hearing aids and open new opportunities for our hearing care professionals," said O'Neil.
  • In addition to highly innovative hearing aids, Signia also delivers tools and apps to increase customer interaction and engagement at all levels of hearing aid management.
  • Signia allows hearing care professionals and hearing aid wearers not just to correct a hearing loss but to gain an edge to Be Brilliant.